CompletedNot Applicable

Improving the Exposure Therapy Through Projection-based Augmented Reality for the Treatment of Cockroach Phobia

Spain4 participantsStarted 2020-09-30

Plain-language summary

The aim of this study is to test the efficacy and efficiency of varying the phobic stimuli during the augmented reality (AR) exposure therapy using multiple stimuli versus one single stimulus through projection-based AR (P-ARET) for the treatment of participants diagnosed with cockroach phobia.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being at least 18 years old * Meeting DSM-5 diagnostic criteria for SP (animal subtype) to cockroaches * Having a minimum of six-month duration of the phobia * Sign an informed consent * Presenting a score of at least 4 on the fear and avoidance scales of the diagnostic interview applied Exclusion Criteria: * Presence of another severe mental disorder that requires immediate attention * Having current alcohol or drug dependence or abuse, psychosis or severe organic illness * Currently being treated in a similar treatment program * Being capable of inserting their hands in a plastic container with a cockroach (during the behavioral test) * Receiving other psychological treatment during the study for cockroach phobia * Start receiving pharmacological treatment during the study (or in case of being already taking them, change the drug or dose)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Behavioral Avoidance Test (BAT; adapted from Öst, Salkovskis, & Hellström's, 1991)

Timeframe: At the beginning of the intervention and immediately after the treatment

Change in fear, avoidance, belief in negative thoughts and coping ability with the feared stimulus levels.

Timeframe: Once a day (from the start of the baseline until the end of the treatment) and at 1, 6 and 12 months after the end of the treatment.

Trial details

NCT IDNCT04553120

SponsorUniversitat Jaume I

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Animal Phobia trials